Continued great news about Pfizer’s Covid pill (Paxlovid): “[it] retained its 89% efficacy at preventing hospitalization and death in the full results of a study of 2,246 high-risk patients”. Pfizer is also confident about its effectiveness vs Omicron.
Advertise here with Carbon Ads
This site is made possible by member support. ❤️
Big thanks to Arcustech for hosting the site and offering amazing tech support.
When you buy through links on kottke.org, I may earn an affiliate commission. Thanks for supporting the site!
kottke.org. home of fine hypertext products since 1998.
Stay Connected